FFCP PHASE1:Hg19::chr17:56349073..56349082,-
From FANTOM5_SSTAR
Jump to: navigation, search
| Short description: | p@chr17:56349073..56349082, - |
|---|---|
| Species: | Human (Homo sapiens) |
| DPI dataset: | Robust |
| TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
| DHS support(Yes/No): | Yes |
| Description: | CAGE_peak_at_chr17:56349073..56349082, - |
| Coexpression cluster: | C209_acute_myelodysplastic_CD34_granulocyte_CD133_liver_spleen |
| Association with transcript: | NA |
| EntrezGene: | NA |
| HGNC: | NA |
| UniProt: | NA |
| Genome view: | ZENBU |
View on UCSC genome browser
Mouse over to see Genome browser image, Click image to go to Genome browser
CAGE Expression
| Sample | p@chr17:56349073..56349082- |
|---|
0
1
2
3
4
5
6
7
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
| Ontology term | p-value | n |
|---|---|---|
| syndrome | 3.30e-40 | 1 |
| hematopoietic system disease | 6.96e-21 | 2 |
| myeloid leukemia | 2.30e-12 | 31 |
| cardiovascular system disease | 3.79e-11 | 4 |
| leukemia | 5.37e-10 | 39 |
| hematologic cancer | 8.01e-08 | 51 |
| immune system cancer | 8.01e-08 | 51 |
Showing 1 to 7 of 7 entries
